Effects of Coffee, Black Tea and Green Tea Consumption on the Risk of Non-Hodgkin’s Lymphoma: A Systematic Review and Dose–Response Meta-Analysis of Observational Studies

References

• Zhang X, Ge Z, Chen B, Liu R, and Gao C: Efficacy and safety evaluation of fludarabine-based chemotherapy regimen for patients with non-Hodgkin lymphoma: A meta-analysis. Medicine (Baltimore) 96, e7781, 2017.
   PubMed Web of Science ®Google Scholar
• Tianjie H, Junshan L, Ling W, and Hongzhi X: Coffee and the risk of lymphoma: a meta-analysis article. Iran J Public Health 45, 1126–1135, 2016.
   PubMed Web of Science ®Google Scholar
• Bellome J, Meyers JF, and Mcgregor DH: Non-Hodgkin’s lymphoma presenting as submandibular swelling and palatal ulceration. J Oral Maxillofac Surg 51, 1278–1281, 1993.
   PubMed Web of Science ®Google Scholar
• Chen F, Hu J, Liu P, Li J, Wei Z, et al. Carotenoid intake and risk of non-Hodgkin lymphoma: a systematic review and dose-response meta-analysis of observational studies. Ann Hematol 96, 957–965, 2017.
   PubMed Web of Science ®Google Scholar
• Parodi S, Merlo FD, and Stagnaro E : Coffee consumption and risk of non-Hodgkin's lymphoma: evidence from the Italian multicentre case-control study. Cancer Causes Control 28, 867–876, 2017.
   PubMed Web of Science ®Google Scholar
• Ouyang Z, Wang Z, and Jin J: Association between tea and coffee consumption and risk of laryngeal cancer: a meta-analysis. Int J Clin Exp Med 7, 5192–5200, 2014.
   PubMed Web of Science ®Google Scholar
• Chei C-L, Loh JK, Soh A, Yuan J-M, and Koh W-P: Coffee, tea, caffeine, and risk of hypertension: The Singapore Chinese Health Study. Eur J Nutr 57, 1333–1342, 2018.
   PubMed Web of Science ®Google Scholar
• Van Dong Hoang AHL, Pham NM, Xu D, and Binns CW: Habitual tea consumption reduces prostate cancer risk in vietnamese men: a case-control study. Asian Pac J Cancer Prev 17, 4939–4944, 2016.
   PubMedGoogle Scholar
• Zhu G, Hua J, Wang Z, She F, and Chen Y: Tea consumption and risk of gallbladder cancer: A meta-analysis of epidemiological studies. Mol Clin Oncol 3, 613–618, 2015.
   PubMed Web of Science ®Google Scholar
• Wang J, Li X, and Zhang D: Coffee consumption and the risk of cutaneous melanoma: a meta-analysis. Eur J Nutr 55, 1317–1329, 2016.
   PubMed Web of Science ®Google Scholar
• Zheng J-S, Yang J, Fu Y-Q, Huang T, Huang Y-J, et al. Effects of green tea, black tea, and coffee consumption on the risk of esophageal cancer: a systematic review and meta-analysis of observational studies. Nutr Cancer 65, 1–16, 2013.
   PubMed Web of Science ®Google Scholar
• Huang C-C, Lee W-T, Tsai S-T, Ou C-Y, Lo H-I, et al. Tea consumption and risk of head and neck cancer. PLoS One 9, e965072014.
   PubMed Web of Science ®Google Scholar
• Naganuma T, Kuriyama S, Kakizaki M, Sone T, Nakaya N, et al. Green tea consumption and hematologic malignancies in Japan: the Ohsaki study. Am J Epidemiol 170, 730–738, 2009.
   PubMed Web of Science ®Google Scholar
• Chang ET, Smedby KE, Zhang SM, Hjalgrim H, Melbye M, et al. Dietary factors and risk of non-hodgkin lymphoma in men and women. Cancer Epidemiol Biomarkers Prev 14, 512–520, 2005.
   PubMed Web of Science ®Google Scholar
• Chiu BC, Dave BJ, Ward MH, Fought AJ, Hou L, et al. Dietary factors and risk of t(14;18)-defined subgroups of non-Hodgkin lymphoma. Cancer Causes Control 19, 859–867, 2008.
   PubMed Web of Science ®Google Scholar
• Franceschi S, Serraino D, Carbone A, Talamini R, and La Vecchia C: Dietary factors and non-Hodgkin's lymphoma: a case-control study in the northeastern part of Italy. Nutr Cancer 12, 333–341, 1989.
   PubMed Web of Science ®Google Scholar
• Jacobsen BK, Bjelke E, Kvale G, and Heuch I: Coffee drinking, mortality, and cancer incidence: results from a Norwegian prospective study. J Natl Cancer Inst 76, 823–831, 1986.
   PubMed Web of Science ®Google Scholar
• Stensvold I, and Jacobsen BK: Coffee and cancer: a prospective study of 43,000 Norwegian men and women. Cancer Causes Control 5, 401–408, 1994.
   PubMed Web of Science ®Google Scholar
• Tavani A, Negri E, Franceschi S, Talamini R, and La Vecchia C: Coffee consumption and risk of non-Hodgkin's lymphoma. Eur J Cancer Prev 3, 351–356, 1994.
   PubMedGoogle Scholar
• Ugai T, Matsuo K, Sawada N, Iwasaki M, Yamaji T, et al. Coffee and Green Tea Consumption and Subsequent Risk of Malignant Lymphoma and Multiple Myeloma in Japan: The Japan Public Health Center-based Prospective Study. Cancer Epidemiol Biomarkers Prev 26, 1352–1356, 2017.
   PubMed Web of Science ®Google Scholar
• Ward MH, Zahm SH, Weisenburger DD, Gridley G, Cantor KP, et al. Dietary factors and non-Hodgkin's lymphoma in Nebraska (United States). Cancer Causes Control 5, 422–432, 1994.
   PubMed Web of Science ®Google Scholar
• Zhang M, Zhao X, Zhang X, and Holman CD: Possible protective effect of green tea intake on risk of adult leukaemia. Br J Cancer 98, 168–170, 2008.
   PubMed Web of Science ®Google Scholar
• Zheng W, Doyle TJ, Kushi LH, Sellers TA, Hong CP, et al. Tea consumption and cancer incidence in a prospective cohort study of postmenopausal women. Am J Epidemiol 144, 175–182, 1996.
   PubMed Web of Science ®Google Scholar
• Parodi S, Santi I, Marani E, Casella C, Puppo A, et al. Lifestyle factors and risk of leukemia and non-Hodgkin's lymphoma: a case-control study. Cancer Causes Control 27, 367–375, 2016.
   PubMed Web of Science ®Google Scholar
• Nilsson LM, Johansson I, Lenner P, Lindahl B, and Van Guelpen B: Consumption of filtered and boiled coffee and the risk of incident cancer: a prospective cohort study. Cancer Causes Control 21, 1533–1544, 2010.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, and Altman DG: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151, 264–269, 2009.
   PubMed Web of Science ®Google Scholar
• Stang A: Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25, 603–605, 2010.
   PubMed Web of Science ®Google Scholar
• DerSimonian R, and Laird N: Meta-analysis in clinical trials. Control Clin Trials 7, 177–188, 1986.
   PubMed Web of Science ®Google Scholar
• Higgins J, and Green S: Handbook for systematic reviews of interventions version 5.1. 0 [updated March 2011]. The Cochrane Collaboration 5, 252–258, 2011.
   Google Scholar
• Greenland S, and Longnecker MP: Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol 135, 1301–1309, 1992.
   PubMed Web of Science ®Google Scholar
• Berlin JA, Longnecker MP, and Greenland S: Meta-analysis of epidemiologic dose-response data. Epidemiology 4, 218–228, 1993.
   PubMed Web of Science ®Google Scholar
• Orsini N, Bellocco R, and Greenland S: Generalized least squares for trend estimation of summarized dose–response data. The Stata Journal 6, 40–57, 2006.
   Web of Science ®Google Scholar
• Durrleman S, and Simon R: Flexible regression models with cubic splines. Stat Med 8, 551–561, 1989.
   PubMed Web of Science ®Google Scholar
• Egger M, Smith GD, Schneider M, and Minder C: Bias in meta-analysis detected by a simple, graphical test. BMJ 315, 629–634, 1997.
   PubMed Web of Science ®Google Scholar
• Tavani A, Pregnolato A, Negri E, Franceschi S, Serraino D, et al. Diet and risk of lymphoid neoplasms and soft tissue sarcomas. Nutr Cancer 27, 256–260, 1997.
   PubMed Web of Science ®Google Scholar
• Balasubramaniam G, Saoba S, Sarade M, and Pinjare S: Case-control study of risk factors for Non-Hodgkin lymphoma in Mumbai, India. Asian Pac J Cancer Prev 14, 775–780, 2013.
   PubMedGoogle Scholar
• Ludwig IA, Clifford MN, Lean ME, Ashihara H, and Crozier A: Coffee: biochemistry and potential impact on health. Food Funct 5, 1695–1717, 2014.
   PubMed Web of Science ®Google Scholar
• Bøhn SK, Blomhoff R, and Paur I: Coffee and cancer risk, epidemiological evidence, and molecular mechanisms. Mol Nutr Food Res 58, 915–930, 2014.
   PubMed Web of Science ®Google Scholar
• Loftfield E, Shiels MS, Graubard BI, Katki HA, Chaturvedi AK, et al. Associations of coffee drinking with systemic immune and inflammatory markers. Cancer Epidemiol Biomarkers Prev 24, 1052–1060, 2015.
   PubMed Web of Science ®Google Scholar
• Skrabek P, Turner D, and Seftel M: Epidemiology of non-Hodgkin lymphoma. Transfus Apher Sci 49, 133–138, 2013.
   PubMed Web of Science ®Google Scholar
• Bassig BA, Lan Q, Rothman N, Zhang Y, and Zheng T: Current understanding of lifestyle and environmental factors and risk of non-hodgkin lymphoma: an epidemiological update. J Cancer Epidemiol 2012, 1–27, 2012.
   Google Scholar
• Fang H-F, Miao N-F, Chen C-D, Sithole T, and Chung M-H: Risk of cancer in patients with insomnia, parasomnia, and obstructive sleep apnea: a nationwide nested case-control study. J Cancer 6, 1140–1147, 2015.
   PubMed Web of Science ®Google Scholar
• Zhong S, Chen Z, Yu X, Chen W, Lv M, et al. Tea consumption and leukemia risk: a meta-analysis. Tumour Biol 35, 5205–5212, 2014.
   PubMedGoogle Scholar
• Bertolini F, Fusetti L, Rabascio C, Cinieri S, Martinelli G, et al. Inhibition of angiogenesis and induction of endothelial and tumor cell apoptosis by green tea in animal models of human high-grade non-Hodgkin's lymphoma. Leukemia 14, 1477–1482, 2000.
   PubMed Web of Science ®Google Scholar
• Lee YK, Bone ND, Strege AK, Shanafelt TD, Jelinek DF, et al. VEGF receptor phosphorylation status and apoptosis is modulated by a green tea component, epigallocatechin-3-gallate (EGCG), in B-cell chronic lymphocytic leukemia. Blood 104, 788–794, 2004.
   PubMed Web of Science ®Google Scholar
• Yuan J-M, Sun C, and Butler LM: Tea and cancer prevention: epidemiological studies. Pharmacol Res 64, 123–135, 2011.
   PubMed Web of Science ®Google Scholar
• Noda C, He J, Takano T, Tanaka C, Kondo T, et al. Induction of apoptosis by epigallocatechin-3-gallate in human lymphoblastoid B cells. Biochem Biophys Res Commun 362, 951–957, 2007.
   PubMed Web of Science ®Google Scholar
• Annabi B, Currie J-C, Moghrabi A, and Béliveau R: Inhibition of HuR and MMP-9 expression in macrophage-differentiated HL-60 myeloid leukemia cells by green tea polyphenol EGCg. Leuk Res 31, 1277–1284, 2007.
   PubMed Web of Science ®Google Scholar
• Graham HN: Green tea composition, consumption, and polyphenol chemistry. Prev Med 21, 334–350, 1992.
   PubMed Web of Science ®Google Scholar
• Matsuo K, Suzuki R, Hamajima N, Ogura M, Kagami Y, et al. Association between polymorphisms of folate- and methionine-metabolizing enzymes and susceptibility to malignant lymphoma. Blood 97, 3205–3209, 2001.
   PubMed Web of Science ®Google Scholar
• Cancer IAfRo: Coffee, tea, mate, methylxanthines and methylglyoxal. IARC Monogr Eval Carcinogenic Risks Hum 51, 217–233, 1991.
   Google Scholar
• Yang CS, and Wang Z-Y: Tea and cancer. J Natl Cancer Inst 85, 1038–1049, 1993.
   PubMed Web of Science ®Google Scholar
• Gao YT, McLaughlin JK, Blot WJ, Ji BT, Dai Q, et al. Reduced risk of esophageal cancer associated with green tea consumption. J Natl Cancer Inst 86, 855–858, 1994.
   PubMed Web of Science ®Google Scholar
• Hansson LE, Nyrén O, Bergström R, Wolk A, Lindgren A, et al. Diet and risk of gastric cancer. A population-based case-control study in Sweden. Int J Cancer 55, 181–189, 1993.
   PubMed Web of Science ®Google Scholar
• Olsen J, and Kronborg O: Coffee, tobacco and alcohol as risk factors for cancer and adenoma of the large intestine. Int J Epidemiol 22, 398–402, 1993.
   PubMed Web of Science ®Google Scholar
• Zatonski W, Boyle P, Przewozniak K, Maisonneuve P, Drosik K, et al. Cigarette smoking, alcohol, tea and coffee consumption and pancreas cancer risk: a case-control study from Opole, Poland . Int J Cancer 53, 601–607, 1993.
   PubMed Web of Science ®Google Scholar